Esperion Therapeutics CLO Benjamin Looker Sells 11,824 Shares for Tax Withholding

Benjamin Looker, Chief Legal Officer of Esperion Therapeutics, Inc., filed a Form 4 disclosing the sale of 11,824 shares of common stock on June 17, 2026, at a price of $3.155 per share. The transaction was executed to satisfy tax obligations on vested restricted stock units. Following the sale, Looker retains 667,524 shares of Esperion Therapeutics common stock. The filing includes a power of attorney document dated December 13, 2021, authorizing Sheldon Koenig and Richard Bartram to file SEC forms on Looker's behalf. The transaction represents a routine tax-related sale of vested equity compensation rather than a discretionary market sale.